ON 08
Alternative Names: ON-08Latest Information Update: 12 Jul 2024
At a glance
- Originator OncoOne
- Class Antidementias; Bispecific antibodies
- Mechanism of Action Macrophage migration-inhibitory factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alzheimer's disease; Multiple sclerosis
Most Recent Events
- 26 Jun 2024 Early research in Alzheimer's disease in Austria (Parenteral) (OncoOne pipeline, June 2024)
- 26 Jun 2024 Early research in Multiple sclerosis in Austria (Parenteral) (OncoOne pipeline, June 2024)